Literature DB >> 19770439

Mortality of bullous skin disorders from 1979 through 2002 in the United States.

Jessica Risser1, Kevan Lewis, Martin A Weinstock.   

Abstract

OBJECTIVES: To identify and analyze trends in bullous disease mortality from 1979 through 2002 in the United States.
DESIGN: Retrospective population-based analysis.
SETTING: Mortality records from the Centers for Disease Control and Prevention mortality database. PARTICIPANTS: Mortality records from 1979 through 2002 for persons who died of bullous disease. MAIN OUTCOME MEASURES: Age-adjusted mortality rates and trends for 4 bullous disease subgroups: toxic epidermal necrolysis, pemphigoid, pemphigus, and epidermolysis bullosa.
RESULTS: The overall age-adjusted (to the 2000 US standard population) annual mortality rate from bullous diseases of the skin was 0.103 death per 100 000. The average mortality from bullous disorders was 0.098 per 100 000 in 1979 through 1982 and remained stable at 0.099 per 100 000 during the final 4 years of the study, 1999 through 2002. Pemphigoid had a significant increase in mortality from 1979 through 2002, while pemphigus demonstrated a significant decrease in mortality. The mortality rate for toxic epidermal necrolysis was much higher among blacks (0.192 death per 100 000) than whites (0.025 per 100 000) (P < .001), with a mortality rate ratio of 7.57 (95% confidence interval, 6.97-8.21).
CONCLUSIONS: Overall mortality from bullous diseases remained stable from 1979 through 2002, although an increasing mortality from pemphigoid and a decreasing mortality from pemphigus occurred during this period. A very large racial disparity in mortality from toxic epidermal necrolysis was observed.

Entities:  

Mesh:

Year:  2009        PMID: 19770439     DOI: 10.1001/archdermatol.2009.205

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  12 in total

1.  A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone.

Authors:  R P Hall; J Fairley; D Woodley; V P Werth; D Hannah; R D Streilein; J McKillip; J Okawa; M Rose; L L Keyes-Elstein; A Pinckney; A Overington; J Wedgwood; L Ding; B Welch
Journal:  Br J Dermatol       Date:  2015-02-05       Impact factor: 9.302

2.  Epidermolysis bullosae.

Authors:  A N Prasad
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Association between schizophrenia and an autoimmune bullous skin disease-pemphigus: a population-based large-scale study.

Authors:  K Kridin; S Zelber-Sagi; D Comaneshter; A D Cohen
Journal:  Epidemiol Psychiatr Sci       Date:  2017-09-25       Impact factor: 6.892

4.  Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009.

Authors:  Katherine E Brick; Chad H Weaver; Christine M Lohse; Mark R Pittelkow; Julia S Lehman; Michael J Camilleri; Mustafa Al-Hashimi; Carilyn N Wieland
Journal:  J Am Acad Dermatol       Date:  2014-04-03       Impact factor: 11.527

Review 5.  Pemphigus group: overview, epidemiology, mortality, and comorbidities.

Authors:  Khalaf Kridin
Journal:  Immunol Res       Date:  2018-04       Impact factor: 2.829

6.  Evaluation of early and late presentation of patients with ocular mucous membrane pemphigoid to two major tertiary referral hospitals in the United Kingdom.

Authors:  G P Williams; C Radford; P Nightingale; J K G Dart; S Rauz
Journal:  Eye (Lond)       Date:  2011-07-29       Impact factor: 3.775

Review 7.  Pemphigus autoimmunity: hypotheses and realities.

Authors:  Sergei A Grando
Journal:  Autoimmunity       Date:  2011-09-23       Impact factor: 2.815

Review 8.  Bullous Drug Reactions.

Authors:  Maja Mockenhaupt
Journal:  Acta Derm Venereol       Date:  2020-02-12       Impact factor: 3.875

9.  Inherited epidermolysis bullosa: clinical and therapeutic aspects.

Authors:  Vanessa Lys Simas Yamakawa Boeira; Erica Sales Souza; Bruno de Oliveira Rocha; Pedro Dantas Oliveira; Maria de Fátima Santos Paim de Oliveira; Vitória Regina Pedreira de Almeida Rêgo; Ivonise Follador
Journal:  An Bras Dermatol       Date:  2013 Mar-Apr       Impact factor: 1.896

10.  Mortality and Comorbidity Profiles of Patients with Bullous Pemphigoid in Korea.

Authors:  Hyeon Woo Jeon; Sook Jung Yun; Seung-Chul Lee; Young Ho Won; Jee-Bum Lee
Journal:  Ann Dermatol       Date:  2017-12-26       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.